The beautiful metropolis, Shanghai will provide a perfect setting for the Annual Congress of International Drug Discovery Science & Technology. IDDST initiated since 2003, it has been successfully hosted in Shanghai (China), Beijing (China), Shenzhen (China), Nanjing (China), Haikou (China), Suzhou (China), Xi’an (China), Gyeonggi (South Korea), Osaka (Japan), Boston (USA) and Kyoto (Japan) and has attracted more than 10000 participants from over 50 countries and regions in the previous years. IDDST will keep expanding with magnificent scientific and social programs to maximize your network in a free communication meeting environment.
● Inviting Worldwide Distinguished Experts in the Area of Drug Discovery for the Grand Thought
● Collision from more than 30 Countries Designing over 50 Sessions of Scientific Forums and Symposia
● Shooting for more than 200 Oral Presentations in whole Spectrum of Drug Discovery Fields
● Gathering at least 30 Exhibitors in Cutting-edge Technologies and Novel Bioproducts
● Bringing in 20 and more Professional Media Supporters
● Scheduling 5 Sessions of Business & Career Development, and Talent Search
● Multi-Zones of Poster Show and Exhibitions of New Finding, New IP, New Tech and Products
|
Chapter 1: Opening Ceremony and Keynote Forum |
|
|
Chapter 2: Parallel Forums |
|
|
Forum 1: Early Drug Discovery |
|
|
Track 1: Target Identification and Validation |
Track 2: Hit Identification and Optimization |
|
Track 3: Lead Generation and Optimization |
Track 4: Active Pharmaceutical Ingredients |
|
Forum 2: Preclinical Research |
|
|
Track 5: Chemical Manufacture and Control |
Track 6: Pharmacokinetics/ Pharmacodynamics |
|
Track 7: Drug Safety Evaluation |
Track 8: Formulation Optimization & Improving Bioavailability |
|
Forum 3: Investigational New Drug Application |
|
|
Track 9: IND-enabling Studies |
Track 10: IND Application |
|
Forum 4: Clinical Research |
|
|
Track 11: Phase I Clinical Trials |
Track 12: Phase II Clinical Trials |
|
Track 13: Phase III Clinical Trials |
— |
|
Forum 5: Regulatory Approval and Post Approval |
|
|
Track 14: New Drug Application |
Track 15: Post-Approval Research & Monitoring |
|
Chapter 3: Posters and Exhibition |
|
|
Chapter 4: Social Activities and Cultural Events |
|
|
|
Dr. Anil K. Agarwal, Associate Professor, Northwestern University, USA
|
|
Dr. Mark Bradley, Chair and Centre Lead, Queen Mary University of London, UK
|
|
Dr. Renfeng Guo, CSO, Inflarx Pharmaceutical Inc., USA |
|
|
Dr. Jens Erik Nielsen, Vice President, Enzyme Research, Novozymes A/S, Denmark |
|
Dr. Thomas Wittlinger, Professor, Goslar Hospital, Germany |
|
Dr. Muxiang Zhou, Professor, Emory University School of Medicine, USA |
|
|
Dr. Frank Yu Wang, Professor of Chemistry, University of North Carolina, USA |
|
Dr. Da Zhi Liu, Professor, University of California at Davis; Founder, Mirnova Therapeutics, Inc., USA |
|
Dr. Guang Sun, Professor, Memorial University of Newfoundland, Canada |
|
|
Dr. Horacio N. Pappa, Senior Director, United States Pharmacopeia, USA |
|
Dr. Franklin Wong, Professor, The University of Texas M. D. Anderson Cancer Center, USA |
|
Dr. Michael Castagna, Chief Executive Officer, MannKind Corporation, USA |
|
|
Dr. Jasmina Novakovic, Principal Scientist, Simulations Plus, Inc., USA |
|
Dr. Bernat Kocsis, Associate Professor, Beth Israel Deaconess Medical Center, USA |
|
Dr. Chuanxi Cai, Associate Professor, Albany Medical College, USA |
|
|
Dr. Maliha Zahid, Associate Professor, Mayo Clinic, USA |
|
Dr. Aneta Nitsch-Osuch, Professor, Medical University of Warsaw, Poland |
|
Dr. Alexander Tuzikov, Professor, National Academy of Sciences of Belarus, Belarus |
|
|
Dr. Xiaojian Yao, Director, Laboratory of Molecular Human Retrovirology, University of Manitoba, Canada |
|
Dr. Ruola Ning, Professor, University of Rochester, USA |
|
Dr. Maliha Zahid, Associate Professor, Mayo Clinic, USA |
|
|
Dr. Zhangguo Chen, Research Associate Professor, University of Pittsburgh, USA |
|
Dr. Keun-Hwa Lee, Professor, Hanyang University, South Korea |
|
Dr. Chongyang Liang, Professor, School of Pharmaceutical Sciences, Jilin University, China |
|
|
Dr. Jing H Wang, Associate Professor, University of Pittsburgh, USA |
|
Dr. Haoran Yu, Principal Investigator, College of Chemical and Biological Engineering, Zhejiang University, China |
|
Dr. Cheng Chi-Feng, Professor, Department of Oncology, Taipei City United Hospital, Taiwan |
|
|
Dr. Bing Li, Associate Professor, University of Louisville, USA |
|
Dr. Phoency F.-H. Lai, Professor, University of Shanghai for Science and Technology, China |
|
Dr. Khalid Asadi, University of Auckland, New Zealand |
|
|
Dr. Danyun Zeng, Associate Researcher, Innovation Academy for Precision Measurement Science and Technology, CAS, China |
|
Dr. Catalin Mihalcioiu, Assistant Professor, University of Montreal Research Center (CRCHUM), Canada |
|
Dr. Oleg Kshivets, Head of Surgery Department, Bagrationovsk Hospital, Kaliningrad Oblast, Russia |
|
|
Dr. Yu-Xiang Fang, Associated Investigator, Shanghai Jiao Tong University, China
|
|
Dr. Silvia Gartner, Pediatric Pulmonology and Cystic Fibrosis Unit, Hospital Universitari Vall d'Hebron, Spain |
|
Dr. Xiaolei Zhu, Assistant Professor, Johns Hopkins University, USA
|
 |
Dr. Adel K. El-Naggar, Professor, University of Texas, MD Anderson Cancer Center, USA |  |
Dr. Wenliang Li, Professor, University of Texas Health Science Center at Houston, USA |  |
Dr. Kausilia K. Krishnadath, Professor, University of Antwerp, Belgium |
 |
Dr. Alex Dyson, Associate Professor, King's College London, UK |  |
Dr. Songhai Chen, Associate Professor, University of Iowa, USA |  |
Dr. Yang Liu, Senior Scientist II, Scientific Liaison-General Chapters, US Pharmacopeia, USA |
IDDST-2024 provides an ideal platform to showcase your novel technologies and products. It is developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits.
Why Reserve a Booth at IDDST-2024
• To Meet Face-to-Face with the International Movers and Shakers
• To Meet with Key Decision Marker
• To Explore Business Opportunities
• To Spotlight Advanced Technologies and Their Scientific and Commercial Applications
• To Take Advantage of the Conference's Captive Audience and Networking Opportunities within the Exhibition Hall
  |
----------------------Contact Us---------------------- |